Group 1 - The Hang Seng Biotechnology Index futures will be listed for trading on November 28, reflecting the overall performance of the biotechnology sector in the Hong Kong stock market, covering notable companies such as Innovent Biologics, BeiGene, WuXi Biologics, and others, and is expected to benefit from the overseas expansion of innovative drugs and AI healthcare market trends [2][3] Group 2 - On November 28, a total of 11 companies will have their restricted shares unlocked, with a total of 109 million shares, amounting to a market value of 2.599 billion yuan at the latest closing price, with Shandong Water Gas and EVE Energy leading in terms of share unlock volume [4] - 16 companies have disclosed stock repurchase progress on November 28, with one company proposing a repurchase exceeding 40 million yuan, and another company, Guizhou Sanli, disclosing a repurchase plan of up to 1.432 million yuan [5]
今日看点｜恒生生物科技指数期货上市
Sou Hu Cai Jing·2025-11-28 03:10